Prijs Albert Van Dyck voor fundamenteel of klinisch onderzoek over leukemie

The Prijs Albert Van Dyck is an award for fundamental or clinical research on leukemia (or subsidiarily on other human diseases considered incurable or lethal). It recognises an individual researcher or two collaborating researchers for a scientific dissertation or a bundle of publications on the subject. The work may be written in Dutch, French or English and may be a thesis; the award carries a monetary prize.

Monetary prize of 2,500 euro.

An individual researcher or two collaborating researchers may apply. Preference is given to young researchers who continue their scientific work. Candidates must not have applied in the twelve months before the submission deadline for a prize of the Royal Academy, must not be laureates of a category 1, 2 or 3 prize of the Academy, and must not be a member of a Royal Academy of Belgium. The submitted work must be a scientific dissertation or a bundle of publications on leukemia (or subsidiarily on another incurable or lethal human disease) and may be a thesis; it must be in Dutch, French or English.

Complete the web application form; include a one-page summary and attach a file with the Web of Science search results listing the 50 most cited publications and a PDF of up to 10 relevant publications by the candidate (or a thesis). Do not send other documents.